The Escalating Costs of in-Licensing Means That in-House Product Development is Fast Becoming Essential for Specialty
The Escalating Costs of in-Licensing Means That in-House Product Development is Fast Becoming Essential for Specialty
RedNova - Mar 30 6:04 AM
Research and Markets (http://www.researchandmarkets.com/reports/c31637) has announced the addition of Changing Market Dynamics Fuel the Evolution of Specialty Pharma to their offering.Save to My Web
